Mapping and ablating ventricular premature contractions that trigger ventricular fibrillation: trigger elimination
1Cardiovascular Division, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Journal of Cardiovascular Electrophysiology
|September 13, 2014
Summary
Ablation therapy effectively targets ventricular fibrillation (VF) triggers, often originating from premature ventricular contractions (VPCs). Identifying earliest activation sites and modifying cardiac substrates are key to successful VF suppression.
Area of Science:
- Cardiology
- Electrophysiology
- Cardiac Arrhythmias
Background:
- Ventricular fibrillation (VF) is a life-threatening arrhythmia.
- VF is typically triggered by premature ventricular contractions (VPCs) during cardiac repolarization.
- Ablation therapy is an increasingly utilized treatment for VF.
Purpose of the Study:
- To review targets and methods for ablation therapy in VF.
- To highlight the importance of electrocardiogram (ECG) recording for identifying VPC origins.
- To discuss strategies for successful ablation, including pacemapping and substrate modification.
Main Methods:
- Review of ablation targets, including Purkinje potentials and the right ventricular outflow tract (RVOT).
- Emphasis on 12-lead ECG recording for regionalizing VPC origin.
- Discussion of mapping techniques focused on earliest activation and pacemapping when needed.
- Consideration of pulmonary artery (PA) electrical isolation for specific VT types.
Main Results:
- Successful ablation requires precise identification of the earliest activation site.
- Purkinje network modification or PA electrical isolation can suppress VF/VT.
- Eliminating triggering VPCs and modifying reentry circuits are crucial for VF suppression.
Conclusions:
- Ablation therapy is a viable option for managing VF triggers.
- Accurate mapping and understanding of arrhythmogenic substrates are essential for effective ablation.
- Further research is needed to fully elucidate VF mechanisms and optimize ablation strategies.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
1.1K
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
1.1K
Dysrhythmias III: Characteristics of Dysrhythmias
695
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
695
Disturbances in Heart Rhythm
5.2K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.2K
Dysrhythmias VI: Management of Dysrhythmias
593
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
593
Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
Dysrhythmias II: Classification of Tachyarrhythmias
734
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
734


